Payment overview · 2025
General Payments
$37.08
2 reported records · 2 companies
Healthcare provider profile · identity verified
James Timothy Phoenix, MD
Allopathic & Osteopathic Physicians|Internal Medicine · TULSA, OK · NPI 1649311309
Verified facts
What the public records show
CMS Open Payments records show James Timothy Phoenix, MD received $37.08 in general payments during 2025 across 2 reported records.
Pharmacosmos Therapeutics Inc. accounted for 61.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Pharmacosmos Therapeutics Inc. | Unresolved — no canonical attribution shown | $22.94 | 61.9% | 1 | 2025 |
| Smith+Nephew, Inc. | Unresolved — no canonical attribution shown | $14.14 | 38.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $37.08 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| MONOFERRIC Normalized: monoferric |
Drug | Pharmacosmos Therapeutics Inc. | $22.94 | 1 | 2025 |
Source payment records
|
|||||
| COLLAGENASE SANTYL Normalized: collagenase santyl |
Drug | Smith+Nephew, Inc. | $14.14 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 508 | 229 |
| Amlodipine Besylate | Amlodipine Besylate | 451 | 182 |
| Levothyroxine Sodium | Levothyroxine Sodium | 362 | 145 |
| Lisinopril | Lisinopril | 306 | 149 |
| Losartan Potassium | Losartan Potassium | 277 | 111 |
| Gabapentin | Gabapentin | 222 | 85 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 217 | 90 |
| Tramadol Hcl | Tramadol Hcl | 207 | 64 |
| Hydrochlorothiazide | Hydrochlorothiazide | 201 | 95 |
| Omeprazole | Omeprazole | 196 | 80 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 196 | 80 |
| Metoprolol Succinate | Metoprolol Succinate | 190 | 76 |
| Metformin Hcl | Metformin Hcl | 187 | 82 |
| Tamsulosin Hcl | Tamsulosin Hcl | 179 | 61 |
| Pantoprazole Sodium | Pantoprazole Sodium | 163 | 61 |
| Simvastatin | Simvastatin | 153 | 62 |
| Furosemide | Furosemide | 147 | 59 |
| Metoprolol Tartrate | Metoprolol Tartrate | 144 | 49 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 141 | 49 |
| Eliquis | Apixaban | 139 | 30 |
| Alprazolam | Alprazolam | 137 | 42 |
| Potassium Chloride | Potassium Chloride | 130 | 49 |
| Alendronate Sodium | Alendronate Sodium | 127 | 55 |
| Trazodone Hcl | Trazodone Hcl | 126 | 45 |
| Zolpidem Tartrate | Zolpidem Tartrate | 125 | 39 |
| Glipizide | Glipizide | 120 | 40 |
| Citalopram Hbr | Citalopram Hydrobromide | 102 | 34 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 99 | 31 |
| Valsartan | Valsartan | 96 | 33 |
| Meloxicam | Meloxicam | 95 | 38 |
| Atenolol | Atenolol | 92 | 40 |
| Ozempic | Semaglutide | 89 | 24 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 88 | 19 |
| Sertraline Hcl | Sertraline Hcl | 85 | 32 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 81 | 34 |
| Montelukast Sodium | Montelukast Sodium | 79 | 30 |
| Duloxetine Hcl | Duloxetine Hcl | 77 | 26 |
| Clopidogrel | Clopidogrel Bisulfate | 75 | 32 |
| Allopurinol | Allopurinol | 71 | 31 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 69 | 27 |
| Pravastatin Sodium | Pravastatin Sodium | 69 | 30 |
| Hydralazine Hcl | Hydralazine Hcl | 67 | 24 |
| Clonazepam | Clonazepam | 66 | 18 |
| Fluoxetine Hcl | Fluoxetine Hcl | 63 | 19 |
| Warfarin Sodium | Warfarin Sodium | 62 | 26 |
| Mounjaro | Tirzepatide | 58 | 16 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 53 | 19 |
| Pregabalin | Pregabalin | 51 | 22 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 50 | 17 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 49 | 11 |
| Donepezil Hcl | Donepezil Hcl | 47 | 13 |
| Famotidine | Famotidine | 46 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 44 | 18 |
| Mirtazapine | Mirtazapine | 44 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 44 | 17 |
| Escitalopram Oxalate | Escitalopram Oxalate | 43 | 21 |
| Carvedilol | Carvedilol | 40 | 22 |
| Diclofenac Sodium | Diclofenac Sodium | 40 | 13 |
| Oxycodone Hcl | Oxycodone Hcl | 40 | 20 |
| Xarelto | Rivaroxaban | 40 | 11 |
| Breo Ellipta | Fluticasone/Vilanterol | 38 | suppressed |
| Bupropion Xl | Bupropion Hcl | 38 | 16 |
| Lorazepam | Lorazepam | 36 | 12 |
| Celecoxib | Celecoxib | 35 | 14 |
| Estradiol | Estradiol | 35 | 14 |
| Nortriptyline Hcl | Nortriptyline Hcl | 35 | suppressed |
| Novolog Flexpen | Insulin Aspart | 35 | suppressed |
| Diazepam | Diazepam | 34 | 13 |
| Ibuprofen | Ibuprofen | 34 | suppressed |
| Lovastatin | Lovastatin | 34 | 15 |
| Telmisartan | Telmisartan | 34 | suppressed |
| Levetiracetam | Levetiracetam | 33 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 32 | 14 |
| Finasteride | Finasteride | 32 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 31 | 13 |
| Pioglitazone Hcl | Pioglitazone Hcl | 31 | 15 |
| Spironolactone | Spironolactone | 31 | 15 |
| Oxybutynin Chloride | Oxybutynin Chloride | 30 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 29 | 12 |
| Nifedipine Er | Nifedipine | 29 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 28 | 12 |
| Memantine Hcl | Memantine Hcl | 28 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 27 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 27 | 20 |
| Tizanidine Hcl | Tizanidine Hcl | 27 | 17 |
| Methylprednisolone | Methylprednisolone | 26 | 26 |
| Synthroid | Levothyroxine Sodium | 26 | 11 |
| Fluconazole | Fluconazole | 25 | 15 |
| Incruse Ellipta | Umeclidinium Bromide | 25 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 24 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 24 | 12 |
| Benazepril Hcl | Benazepril Hcl | 23 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 23 | suppressed |
| Acyclovir | Acyclovir | 22 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 22 | 14 |
| Irbesartan | Irbesartan | 22 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 21 | suppressed |
| Naproxen | Naproxen | 20 | suppressed |
| Prednisone | Prednisone | 20 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 19 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 19 | suppressed |
| Glimepiride | Glimepiride | 19 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 19 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 19 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 18 | 13 |
| Humalog Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Jardiance | Empagliflozin | 18 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 18 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 18 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 18 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 18 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 18 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 18 | 11 |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 17 | suppressed |
| Azithromycin | Azithromycin | 17 | 17 |
| Lactulose | Lactulose | 17 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 16 | suppressed |
| Januvia | Sitagliptin Phosphate | 16 | suppressed |
| Nystatin | Nystatin | 16 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 16 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 16 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 16 | suppressed |
| Trulicity | Dulaglutide | 16 | suppressed |
| Digoxin | Digoxin | 15 | suppressed |
| Lamotrigine | Lamotrigine | 15 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 15 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 15 | 12 |
| Symbicort | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 15 | suppressed |
| Torsemide | Torsemide | 15 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Mupirocin | Mupirocin | 14 | 12 |
| Nitroglycerin | Nitroglycerin | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 13 | suppressed |
| Chlorthalidone | Chlorthalidone | 13 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 13 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 13 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 13 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 13 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 13 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 13 | suppressed |
| Amiloride-Hydrochlorothiazide | Amiloride/Hydrochlorothiazide | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Baclofen | Baclofen | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Linzess | Linaclotide | 12 | suppressed |
| Niacin Er | Niacin | 12 | suppressed |
| Verapamil Sr | Verapamil Hcl | 12 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 11 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 11 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 11 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 11 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 11 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
| Telmisartan-Amlodipine | Telmisartan/Amlodipine | 11 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 11 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $37.08 · 2 records | Pharmacosmos Therapeutics Inc. | COLLAGENASE SANTYL, MONOFERRIC | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error